Association between transforming growth factor-α polymorphism and ankylosing spondylitis: a meta-analysis update

REFERENCES

• Thomas GP, Brown MA. Genetics and genomics of ankylosing spondylitis. Immunol Rev. 2010;233:162–80.
   PubMed Web of Science ®Google Scholar
• Thomas GP, Brown MA. Genomics of ankylosing spondylitis. Discov Med. 2010;10:263–71.
   PubMed Web of Science ®Google Scholar
• Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, et al. Use of immunohistologic and in situ hybridization tech-niques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthr Rheum. 1995; 38:499–505.
   PubMed Web of Science ®Google Scholar
• Sousa E, Caetano-Lopes J, Pinto P, Imentel F, Teles J, Canhao H. Ankylosing spondylitis susceptibility and severity-contribution of TNF gene promoter polymorphisms at positions -238 and -308. Ann N Y Acad Sci. 2009;1173:581–8.
   PubMed Web of Science ®Google Scholar
• Kaijzel EL, Brinkman BM, van Krugten MV, Smith L, Huizinga TW, Verjans GM, et al. Polymorphism within the tumor necrosis factor a (TNF) promoter region in patients with ankylosing spondylitis. Hum Immunol. 1999;60:140–4.
   PubMed Web of Science ®Google Scholar
• Brown MA. Progress in spondylarthritis. Progress in studies of the genetics of ankylosing spondylitis. J Arthr Res Ther. 2009;11(5):254 (Epub 2009 Oct 29, Review).
   Google Scholar
• McGarry F, Walker R, Sturrock R, Field M. The -308.1 poly-morphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27. J Rheumatol. 1999;26: 1110–6.
   Google Scholar
• Gonzalez S, Torre-Alonso JC, Martinez-Bona J, Fernandez Sanchez JA, López-Vazquez A, Rodriguez Perez A, et al. TNF -238 A promoter polymorphism contributes to susceptibility toankylosing spondylitis in HLA-B27 negative patients. J Rheu-matol. 2001;28:1288–93.
   PubMed Web of Science ®Google Scholar
• Milicic A, Lindheimer F, Laval S, Rudwaleit M, Ackerman H, Wordsworth P, et al. Interethnic studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondylitis. Genes Immun. 2000;1:418–22.
   PubMed Web of Science ®Google Scholar
• Rudwaleit M, Siegert S, Yin Z. Low T cell production of TNF-alpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF -308 gene polymorphism. Ann Rheum Dis. 2001;60: 36–42.
   Google Scholar
• Lin JA, Ye DF, et al. Polymerase chain reaction analysis for the tumor necrosis factor alpha -308 gene polymorphism in relation to ankylosing spondylitis. Chin J Rheumatol. 2003;7:420–2.
   Google Scholar
• Liu QH, Teng Y, Wu QM, Shen LX, Wang H, Chen Y, et al. Relationship between polymorphism in promoter regions of tumor necrosis factor gene and ankylosing spondylitis. Chin J Rheumatol. 2002;6:402–5.
   Google Scholar
• Cai Q, Liu CG, Wang YJ, Than Z, Cheng T. Gene polymorphism of the promoter region 308 site of the tumor necrosis factor-a in ankylosing spondylitis. Acad J PLA Postgrad Med Sch. 2007; 28:279–81.
   Google Scholar
• Lu MC, Yang KL, Tung CH, et al. Higher LPS-stimulated TNF-a mRNA levels in peripheral blood mononuclear cells from Chinese ankylosing spondylitis patients with -308 G/A poly-morphism in promoter region of tumor necrosis factor: associa-tion with distinct A33/B58/Cw10 haplotypes. Rheumatol Int. 2008;29:189–95.
   PubMed Web of Science ®Google Scholar
• Shiau MY, Lo MK, Chang CP, Yang TP, Ho KT, Chang YH. Association of tumour necrosis factor alpha promoter polymor-phisms with ankylosing spondylitis in Taiwan. Ann Rheum Dis. 2007;66:562–3.
   PubMed Web of Science ®Google Scholar
• Chung WT, Choe JY, Jong WC, et al. Polymorphisms of tumor necrosis factor-a promoter region for susceptibility to HLA-B27-positive ankylosing spondylitis in Korean population. Rheumatol Int. 2011;31:1167–75.
   PubMed Web of Science ®Google Scholar
• Nicknam MH, Mahmoudi M, Amirzargar AA, Jamshidi AR, Rezaei N, Nikbin B. HLA-B27 subtypes and tumor necrosis factor alpha promoter region polymorphism in Iranian patients with ankylosing spondylitis. Eur Cytokine Netw. 2009;20:17–20.
   PubMed Web of Science ®Google Scholar
• Vargas-Alarcon G, Casasola-Vargas J, Rodriguez-Perez JM, et al. Tumor necrosis factor-alpha promoter polymorphisms in Mexi-can patients with spondyloarthritis. Hum Immunol. 2006;67: 826–32.
   PubMed Web of Science ®Google Scholar
• Yang B, Chen RW, Duan SW, et al. Influence of polymorphism in -238 and -308 sites of TNF- a promoter regions on suscep-tibility and phenotype of ankylosing spondylitis. Acad J Sec Mil Med Univ. 2004;25:125–8.
   Google Scholar
• Martinez-Bona J, Gonzalez S, Lopez-Vazquez A, et al. HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibility. Hum Immunol. 2000;61: 131–9.
   Google Scholar
• Fraile A, Nieto A, Vinasco J, et al. Tumor necrosis factor gene polymorphisms in ankylosing spondylitis. Tissue Antigens. 1998;51:386–90.
   PubMed Web of Science ®Google Scholar
• Hohler T, Schaper T, Schneider PM, Meyer ZBK, MarkerHer-mann E. Association of different tumor necrosis factor lpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum. 1998;41: 1489–92.
   Google Scholar
• Veijans GM, Brinkman BM, Van Doomik CE, et al. Polymor-phism of tumour necrosis factor-alpha (TNF-alpha) at position -308 in relation to ankylosing spondylitis. Clin Exp Immunol. 1994;97:45–7.
   PubMed Web of Science ®Google Scholar
• Chatzikyriakidou A, Georgiou I, Voulgari PV, Drosos AA. The role of tumor necrosis factor (TNF)-alpha and TNF receptorpolymorphisms in susceptibility to ankylosing spondylitis. Clin Exp Rheumatol. 2009;27:645–64.
   PubMed Web of Science ®Google Scholar
• Wang M, Du SJ, etal. Study on the gene polymorphism of TNF-a —238 in ankylosing spondylitis (AS) patients in human popula-tion. Chin J Immunol. 2010;26: 136–40.
   Google Scholar
• Mei YJ. Relationship between gene polymorphism in TNF-a promoter regions and susceptibility to ankylosing spondylitis. Chin J Allergy Cunical Immunol. 2009;3:173–7.
   Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analyses. Stat Med. 2002;21:1539–58.
   PubMed Web of Science ®Google Scholar
• Petitti DB. Meta-analysis, decision analysis, and cost-effective-ness analysis. New York: Oxford University Press; 2000. p. 306.
   Google Scholar
• Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335–71.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey SG, Schneider M, et al. Bias in meta analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
   PubMed Web of Science ®Google Scholar
• Li Bing, Wang Pei. Hui Li.The association between TNF-alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis. Clin Rheumatol. 2010;29:983–90.
   Google Scholar
• Lee YH, Song GG. Lack of association of TNF-apromoter polymorphisms with ankylosing spondylitis: a meta-analysis. Rheumatology. 2009;48:1359–62.
   PubMed Web of Science ®Google Scholar
• Seitz M, Wirthmuller U, Moller B, Villiger PM. The —308 tumour necrosis factor-alpha gene polymorphism predictstherapeutic response to TNF alpha-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology (Oxford). 2007;46:93–6.
   PubMed Web of Science ®Google Scholar
• Poddubnyy DA, Marker-Hermann E, Kaluza-Schilling W, Zei-dler H, Braun J, Listing J, et al. Relation of HLA-B27, tumor necrosis factor-promoter gene polymorphisms, and t cell cytokine production in ankylosing spondylitis—a comprehensive geno-type-phenotype analysis from an observational cohort. J Rheu-matol. 2011;38:11.
   Google Scholar
• Aguillon JC, Cruzat A, Aravena 0, Salazar L, Limos C, Cuch-acovich M. Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution? Immunobiology. 2006;211:75–84.
   Google Scholar
• Bennett PH, Burch TA. New York symposium on population studies in the rheumatic diseases: new diagnostic criteria. Bull Rheum Dis. 1967;17:453.
   Google Scholar
• Van der Linden S, Valkenburg H, Cats A. Evaluation of diag-nostic criteria for ankylosing spondylitis. A proposal for mod-ification of the New York criteria. Arthr Rheum. 1984;27: 361–8.
   PubMed Web of Science ®Google Scholar
• Yang QR, Zhang YC, Su HS, et al. The association between ankylosing spondylitis with polymorphism in —308 site of TNF-a promoter region: the meta analysis. China J Rheumatol. 2007;11: 365–9.
   Google Scholar